July 01, 2019 Big cap stocks grow in first half despite M&A activity, not because of it Indulging in M&A is not the way to bump up share prices as oncology-focused companies prove to be the sector’s darlings.
October 10, 2016 Esmo weekend roundup – Opdivo’s big stumble is Keytruda’s big triumph, plus Yervoy and IDO
